[来自多发性骨髓瘤患者的介质干细胞的最新研究进展--评论]

Xiao-Sui Ling1, Hai-Ping He1, Li-Hua Zhang1

  • 1The Affiliated Hospital of Kunming University of Science and Technology; Department of Hematology, the First People's Hospital of Yunnan Province, Kunming 650032, Yunnan Province, China.

概括

多发性骨髓瘤 (MM) 涉及异常的骨髓介质干细胞 (MM-MSC). 这些MM-MSC影响MM的进展,化学抵抗和免疫功能,突出显示它们在疾病中的关键作用.